ResearchViews Home
Login
Registration
Home
Latest News
Latest Deals
Report Store
Contact Us
Sign up for our FREE Weekly
Hematology Disorders
ResearchViews Update.
Please enter your email address below
*
:
Related Industries
Pharma
Cardiovascular
Central Nervous System
Dermatology
ENT Disorders
Gastroenterology
Genito Urinary System and Sex Hormones
Hematology Disorders
Hormonal Disorders
Immunology
Infectious Disease
Male Health
Metabolic Disorders
Mouth and Dental Disorders
Musculoskeletal
Oncology
Ophthalmology
Respiratory
Women's Health
Medical
Cardiovascular Devices
Dental Devices
Diabetes Care Devices
Diagnostic Imaging
Drug Delivery Devices
Endoscopy Devices
ENT Devices
Healthcare IT
Hospital Supplies
In Vitro Diagnostics
Nephrology and Urology Devices
Neurology Devices
Ophthalmic Devices
Orthopedic Devices
Patient Monitoring
Respiratory Devices
Surgical Equipment
Wound Care Management
"
"
Click Here
Free Research Papers
Latest Hematology Disorders Reports
Latest Hematology Disorders Deals
Spectrum Pharma Enters Into Licensing Agreement With Hanmi Pharma For SPI-2012
Published: Jan 31 2012
Light Sciences Oncology Raises $1.3 Million In Venture Financing
Published: Jan 10 2012
Synta Pharma Completes Public Offering Of Common Stock For $31 Million
Published: Jan 05 2012
Hanall Pharmaceutical Announces Private Placement Of Unsecured Bonds Due 2016 For $7.8 Million
Published: Dec 28 2011
Acceleron Secures $30 Million In Series F Round Of Financing
Published: Dec 23 2011
Latest Hematology Disorders News
Merck Reports Net Sales Of $12.3 Billion In Q4 2011
Date of story: Feb 02 2012
AstraZeneca Reports Revenue Of $8.7 Billion In Q4 2011
Date of story: Feb 02 2012
Allergan Reports Revenue Of $1.4 Billion In Q4 2011
Date of story: Feb 02 2012
Affymax Promotes Cynthia Smith To Vice President, Market Access And Commercial Development
Date of story: Feb 02 2012
AstraZeneca Announces New Restructuring Initiatives To Drive Productivity And Support Innovation
Date of story: Feb 02 2012
Latest Hematology Disorders Reports
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
By: GlobalData, Published: Jan-2012
Chemotherapy Effects - Pipeline Review, H1 2012
By: Global Markets Direct, Published: Jan-2012
Essential Thrombocythemia - Pipeline Review, H1 2012
By: Global Markets Direct, Published: Jan-2012
Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
By: GlobalData, Published: Jan-2012
Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
By: GlobalData, Published: Jan-2012